FDA warns of death risk from codeine in some post-surgery children
from U.S. Food and Drug Administration
The Food and Drug Administration has issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils and/or adenoids. The surgeries were performed to treat obstructive sleep apnea syndrome, a condition that results in repeated episodes of complete or partial blockage of the upper airway during sleep. The children received doses of codeine that were within the typical dose range.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063